;which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof."/>
公开/公告号US2021196693A1
专利类型
公开/公告日2021-07-01
原文格式PDF
申请/专利权人 DECIPHERA PHARMACEUTICALS LLC;
申请/专利号US202117180241
申请日2021-02-19
分类号A61K31/4375;A61K9/10;A61K9;A61K47/38;
国家 US
入库时间 2022-08-24 19:43:08